ES2074422T3 - Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso. - Google Patents

Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.

Info

Publication number
ES2074422T3
ES2074422T3 ES88103003T ES88103003T ES2074422T3 ES 2074422 T3 ES2074422 T3 ES 2074422T3 ES 88103003 T ES88103003 T ES 88103003T ES 88103003 T ES88103003 T ES 88103003T ES 2074422 T3 ES2074422 T3 ES 2074422T3
Authority
ES
Spain
Prior art keywords
dna
molecules
viruses
coded
subtype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88103003T
Other languages
English (en)
Inventor
Franz Xaver Doz Dr Heinz
Christian Prof Dr Kunz
Christian Mag Mandl
Friedrich Prof Dr Dorner
Walter Univ-Doz Dr Bodemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of ES2074422T3 publication Critical patent/ES2074422T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL INVENTO SE REFIERE A LAS MOLECULAS DNA Y RNA, ASI COMO A LAS PROTEINAS Y PEPTIDOS QUE SON CODIFICADOS POR LAS SECUENCIAS DNA Y RNA. ESTAS SECUENCIAS DNA CODIFCAN PEPTIDOS O PROTEINAS CON LA ESPECIFICACION DE PROTEINAS ESTRUCTURALES DEL SUBTIPO OCCIDENTAL DEL VIRUS TBE. LAS MOLECULAS DNA RECOMBINADAS PUEDEN DIRIGIR EN SISTEMAS DE EXPRESION APROPIADOS LA EXPRESION DE LOS PEPTIDOS O PROTEINAS ESPECIFICAS PARA EL SUBTIPO OCCIDENTAL DEL VIRUS TBE, QUE PUEDEN SER USADOS COMO VACUNAS O MEDIOS DE DIAGNOSTICO. LAS SECUENCIAS DNA, PRESENTADAS PUEDEN USARSE TAMBIEN COMO PRUEBAS DE HIBRIDACION.
ES88103003T 1987-03-20 1988-02-29 Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso. Expired - Lifetime ES2074422T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87104114 1987-03-20

Publications (1)

Publication Number Publication Date
ES2074422T3 true ES2074422T3 (es) 1995-09-16

Family

ID=8196853

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88103003T Expired - Lifetime ES2074422T3 (es) 1987-03-20 1988-02-29 Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.

Country Status (4)

Country Link
EP (1) EP0284791B1 (es)
AT (1) ATE122055T1 (es)
DE (1) DE3853693D1 (es)
ES (1) ES2074422T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO902491L (no) * 1989-06-06 1990-12-07 Immuno Aktienges Fuer Chemisch Proteiner, vaksiner og nukleinsyrer.
DE4002521A1 (de) * 1990-01-29 1991-08-01 Immuno Ag Rekombinantes plasmid
SE470074B (sv) * 1990-08-16 1993-11-01 Replico Medical Ab Förfarande för diagnos av picorna- och/eller flavivirusinfektion, peptider, diagnostiska antigener och vaccinkomposition med dessa peptider
HU219503B (hu) * 1994-07-08 2001-04-28 Baxter Aktiengesellschaft Javított vakcina TBE-vírusfertőzés elleni immunizálásra, valamint eljárás az előállítására
DE19613253A1 (de) * 1996-04-02 1997-10-09 Immuno Gmbh Technik zum Nachweis von Infektionen mit dem TBE-Virus und anderen Flaviviren
DE19626614A1 (de) * 1996-07-02 1998-01-08 Immuno Ag Komplex aus Antigen und Zellbestandteil, Impfstoffzusammensetzung, welche den Komplex enthält, pharmazeutische Präparation sowie Verfahren zur Herstellung des Komplexes
EP2325321A1 (en) 1999-05-28 2011-05-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
WO2009024534A2 (en) * 2007-08-17 2009-02-26 Intercell Ag Japanese encephalitis virus (jev) and tick-borne encephalitis virus (tbev) peptides stimulating human t cell responses

Also Published As

Publication number Publication date
EP0284791B1 (de) 1995-05-03
DE3853693D1 (de) 1995-06-08
ATE122055T1 (de) 1995-05-15
EP0284791A1 (de) 1988-10-05

Similar Documents

Publication Publication Date Title
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
DK84194A (da) Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
ES2061500T3 (es) Diagnosis y vacunas de la hepatitis delta su preparacion y uso.
ES2141081T3 (es) Nuevo aislado de hcv j-1.
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ES2115622T3 (es) Clones moleculares de hiv-1 y usos de los mismos.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
CO5650177A2 (es) Constructos geneticos y composiciones que comprenden rre y cte y usos de estos
ATE227026T1 (de) Peptidvakzine auf basis von fusionsproteinen mit onkogenanteil
ES2121754T3 (es) Fragmento de adnc que codifica el gen del receptor del interferon alfa y procedimiento para la preparacion de una proteina correspondiente.
ES2191033T3 (es) Alergenos recombinantes de cladosporium herbarum.
ES2166757T3 (es) Secuencias de adn del virus de epstein-barr que codifican un antigeno de la capsida del virus de interes diagnostico, clones de expresion obtenidos por la reaccion en cadena de la polimerasa y el uso de este antigeno recombinante en ensayos de diagnostico.
FI902814A0 (fi) Proteiner, vaccin och nukleinsyror.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 284791

Country of ref document: ES